| Number at risk | Diabetes cases | Unadjusted | Model 1 | Model 2 | |||
---|---|---|---|---|---|---|---|---|
HR (95Â % CI) | P for trend | HR (95Â % CI) | P for trend | HR (95Â % CI) | P for trend | |||
Normal BP | ||||||||
 Men | ||||||||
  Quartile 1 | 443 | 39 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 444 | 47 | 1.15 (0.75-1.76) | 1.16 (0.76-1.77) | 1.18 (0.77-1.81) | |||
  Quartile 3 | 444 | 61 | 1.53 (1.02-2.28)* | 1.54 (1.03-2.30)* | 1.54 (1.02-2.32)* | |||
  Quartile 4 | 443 | 82 | 2.16 (1.47-3.16)** | 2.21 (1.51-3.23)** | 2.08 (1.39-3.12)** | |||
 Women | ||||||||
  Quartile 1 | 539 | 32 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 539 | 44 | 1.43 (0.91–2.27) | 1.41 (0.89-2.23) | 1.55 (0.98-2.46) | |||
  Quartile 3 | 539 | 49 | 1.60 (1.02–2.51)* | 1.53 (0.98-2.41) | 1.63 (1.03-2.57)* | |||
  Quartile 4 | 539 | 88 | 3.00 (1.97–4.47)** | 2.72 (1.80-4.12)* | 2.58 (1.70-3.94)** | |||
Prehypertension | ||||||||
 Men | ||||||||
  Quartile 1 | 237 | 37 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 237 | 37 | 0.92 (0.58–1.45) | 0.93 (0.59–1.46) | 0.96 (0.60–1.54) | |||
  Quartile 3 | 238 | 37 | 0.98 (0.62–1.55) | 1.01 (0.64–1.59) | 1.03 (0.63–1.68) | |||
  Quartile 4 | 237 | 57 | 1.54 (1.02–2.33)* | 1.65 (1.09–2.50)* | 1.77 (1.12–2.81)* | |||
 Women | ||||||||
  Quartile 1 | 206 | 16 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 203 | 22 | 1.39 (0.73–2.65) | 1.39 (0.73–2.64) | 1.35 (0.70–2.59) | |||
  Quartile 3 | 205 | 41 | 2.78 (1.56 –4.96)* | 2.76 (1.55–4.92)* | 2.66 (1.47–4.79)* | |||
  Quartile 4 | 204 | 48 | 3.23 (1.83–5.69)** | 3.18 (1.80–5.62)** | 2.91 (1.63–5.18)** |